# OnCo record biohaven (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/biohaven/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "biohaven" ;
  schema:name "Biohaven"@en ;
  schema:alternateName "Biohaven Ltd."@en, "Biohaven Ltd"@en ;
  schema:description "A listed US drug company working across several diseases. In cancer it is testing two antibody-drug conjugates, drugs that carry a toxin to cancer cells, in early trials for advanced solid tumours including bladder cancer."@en ;
  schema:url <https://onco.cc/companies/biohaven/>, <https://www.biohaven.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.biohaven.com/>, <https://www.biohaven.com/pipeline/>, <https://clinicaltrials.gov/study/NCT06384807>, <https://clinicaltrials.gov/study/NCT06874335>, <https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001935979>, <https://www.racap.com/portfolio/biohaven> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/trop2/>, <https://onco.cc/targets/fgfr3-receptor/> ;
  onco:drugs <https://onco.cc/drugs/bhv-1510/>, <https://onco.cc/drugs/bhv-1530/> ;
  onco:trials <https://onco.cc/trials/nct06384807/> .
